Q2 2025 Orthofix Medical Inc Earnings Call Transcript
Key Points
- Orthofix Medical Inc (OFIX) reported a 4% year-over-year constant currency growth in pro forma net sales, reaching $200.7 million.
- The USA Spinal Fixation net sales grew by 5.4%, with procedure volume increasing by 7%, indicating strong market performance.
- The company launched the Reef L Lateral Lumbar Interbody System and received FDA clearance for the VIRATA Spinal Fixation System, enhancing their product portfolio.
- Orthofix Medical Inc (OFIX) achieved a 28% growth in USA orthopedics, driven by the successful launch of the TrueLok Elevate Transverse Bone Transport System.
- The Bone Growth Therapies segment exceeded market performance with a 6% growth, supported by strong results in both spine and fracture channels.
- The discontinuation of the M6 artificial disc product lines impacted the company's financial results, requiring adjustments in their reporting.
- A major account's price decrease negatively affected the U.S. Spine Fixation business, offsetting some of the procedure volume growth.
- International Orthopedics business declined by 2% due to the absence of large NGO orders that occurred in the previous year.
- The company faces exposure to tariffs in the EU, Canada, China, and Taiwan, with an estimated annual impact of $3 million to $4 million.
- Orthofix Medical Inc (OFIX) anticipates variability in growth rates due to the timing and volume of stocking distributor and tender orders.
Thank you for standing by. My name is Kayla, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Orthofix Second Quarter 2025 Earnings Call. (Operator Instructions)
I would now like to turn the call over to Julie Dewey. You may begin.
Thank you, operator, and good morning, everyone. Welcome to Orthofix' Second Quarter 2025 Earnings Call. We appreciate you joining us. I'm Julie Dewey, Orthofix's Chief IR and Communications Officer. Joining me on the call today are President and Chief Executive Officer, Massimo Calafiore; and Chief Financial Officer, Julie Andrews.
Before we get started, please note that our earnings release and the supplemental presentation accompanying this call are available on the Events and Presentations page of the Investors section of our corporate website at orthofix.com. Also, this call is being broadcast live over the Internet to all interested parties and an archived copy of this webcast
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
